Organization Overview
Alternative names
cyclophosphamide (cytoxan) (1 trial)
dolutegravir (tivicay) (1 trial)
haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)
Anemia (Phase 2)
Anorexia (Phase 2)
Cachexia (Phase 2)
Cardiovascular Abnormalities (Phase 4)
Coinfection (Phase 2)
Communicable Diseases (Phase 2)
Coronary Artery Disease (Phase 4)
Dengue (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Neuropathies (Phase 3)
Diarrhea (Phase 2)
Dysentery (Phase 2)
Dysentery, Bacillary (Phase 2)
Glucose Intolerance (Phase 4)
Gonorrhea (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Hepatitis C (Phase 4)
Hepatitis E (Phase 2)
Herpes Simplex (Phase 2)
HIV Infections (Phase 4)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 4)
Influenza, Human (Phase 4)
Insulin Resistance (Phase 4)
Kidney Diseases (Phase 3)
Leukopenia (Phase 2)
Malaria (Phase 4)
Malaria, Falciparum (Phase 4)
Osteoarthritis (Phase 3)
Osteoarthritis, Knee (Phase 3)
Parasitic Diseases (Phase 4)
Peripheral Nervous System Diseases (Phase 3)
Peripheral Vascular Diseases (Phase 4)
Prediabetic State (Phase 4)
Schizophrenia (Phase 3)
Severe Dengue (Phase 3)
Shock (Phase 3)
Spasm (Phase 4)
Syphilis (Phase 2)
Thrombocytopenia (Phase 2)
Trichomonas Vaginitis (Phase 2)
Tuberculosis (Phase 2)
Vaginitis (Phase 2)
Vomiting (Phase 4)
Wasting Syndrome (Phase 2)